186 related articles for article (PubMed ID: 2953563)
1. Chinese acupuncture treatment for SMON patients.
Katahira K; Kobayshi T; Higashida T; Kamae S; Nakajima Y; Fujimoto S
Chin Med J (Engl); 1986 Nov; 99(11):910-1. PubMed ID: 2953563
[No Abstract] [Full Text] [Related]
2. Ethnic differences in drugs and xenobiotics. Clioquinol.
Rose FC
Prog Clin Biol Res; 1986; 214():323-30. PubMed ID: 2941765
[No Abstract] [Full Text] [Related]
3. The aetiology of SMON may involve an interaction between clioquinol and environmental metals.
Tjälve H
Med Hypotheses; 1984 Nov; 15(3):293-9. PubMed ID: 6240588
[TBL] [Abstract][Full Text] [Related]
4. [SMON].
Paal G
MMW Munch Med Wochenschr; 1976 Dec; 118(51):suppl [7]-[8]. PubMed ID: 826814
[No Abstract] [Full Text] [Related]
5. [Neurotoxicity of chinoform].
Iwashita H
Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):602-5. PubMed ID: 10434730
[No Abstract] [Full Text] [Related]
6. Outline of the joint SMON investigation by the clinical section.
Kusui K
Jpn J Med Sci Biol; 1975; 28 Suppl():57-62. PubMed ID: 136541
[No Abstract] [Full Text] [Related]
7. Is there SMON in India?
Wadia NH
Neurol India; 1973 Sep; 21(3):95-103. PubMed ID: 4274127
[No Abstract] [Full Text] [Related]
8. Clioquinol intoxication occurring in the treatment of acrodermatitis enteropathica with reference to SMON outside of Japan.
Hanakago R; Uono M
Clin Toxicol; 1981 Dec; 18(12):1427-34. PubMed ID: 6460590
[TBL] [Abstract][Full Text] [Related]
9. [SMON syndrome. First case after abuse of a methylated hydroxyquinoline derivative].
Saragoussi JJ; Soffer M; Giraud D; Raison J; Basdevant A; Pouliquen Y
Bull Soc Ophtalmol Fr; 1984 Jan; 84(1):25-8. PubMed ID: 6442219
[No Abstract] [Full Text] [Related]
10. Oxyquinoline toxicity.
Soffer M; Basdevant A; Sarragoussi JJ; Raison J; Guy-Grand B
Lancet; 1983 Mar; 1(8326 Pt 1):709. PubMed ID: 6132067
[No Abstract] [Full Text] [Related]
11. Assessment of neurotoxicity of clioquinol (Enterovioform) by visual evoked potentials. A preliminary communication.
Bhasin DK; Raina R; Mehta SK; Arora MM
Indian J Gastroenterol; 1985 Jul; 4(3):165-6. PubMed ID: 3160659
[No Abstract] [Full Text] [Related]
12. [SMON outside Japan--a neurologic evaluation].
Silfverskiöld B
Lakartidningen; 1980 May; 77(19):1821-2. PubMed ID: 7392712
[No Abstract] [Full Text] [Related]
13. Subacute myelo-optico-neuropathy (SMON)--neurotoxicity of clioquinols.
Selby G
Proc Aust Assoc Neurol; 1973; 9():23-30. PubMed ID: 4268933
[No Abstract] [Full Text] [Related]
14. [Hydroxyquinoline victims in Sweden].
Hansson O
Lakartidningen; 1978 Sep; 75(36):3064-7. PubMed ID: 682760
[No Abstract] [Full Text] [Related]
15. [The history of quinolines].
Wolffers I
Ned Tijdschr Geneeskd; 1985 Jun; 129(26):1246-9. PubMed ID: 3160957
[No Abstract] [Full Text] [Related]
16. [Epidemiological studies on subacute myelo-optico neuropathy (SMON) in the town of Yubara, Japan. 3].
Aoyama H; Oira M; Ota T; Yoshioka S; Yoshida T
Nihon Eiseigaku Zasshi; 1970 Dec; 25(5):468-71. PubMed ID: 4251106
[No Abstract] [Full Text] [Related]
17. [Analysis of the effects of chinoform on subacute myelo-optico-neuropathy (SMON)--application of linear regression analysis by logistic transformation].
Inoue N; Kuroiwa Y; Ikeda M; Yasukouchi T
Rinsho Shinkeigaku; 1974 Oct; 14(10):769-73. PubMed ID: 4282713
[No Abstract] [Full Text] [Related]
18. [SMON--a model of the iatrogenic disease].
Takasu T
Rinsho Shinkeigaku; 2003 Nov; 43(11):866-9. PubMed ID: 15152488
[TBL] [Abstract][Full Text] [Related]
19. [Subacute myelo-optic neuritis].
Vanĕcek J; Fink Z
Cesk Pediatr; 1979 Nov; 34(11):661-2. PubMed ID: 160840
[No Abstract] [Full Text] [Related]
20. SMON and other socially induced diseases in Japan.
Sonoda K
Soc Sci Med (1967); 1978 Nov; 12(6A):497-506. PubMed ID: 153585
[No Abstract] [Full Text] [Related]
[Next] [New Search]